Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Glycemic control and cardiovascular disease in type 2 diabetes: a review.

Wild SH, Dunn CJ, McKeigue PM, Comte S.

Diabetes Metab Res Rev. 1999 May-Jun;15(3):197-204. Review.

PMID:
10441042
[PubMed - indexed for MEDLINE]
2.

[Management of diabetes in cardiac diseases].

Işik S, Delibaşi T, Berker D, Aydin Y, Güler S.

Anadolu Kardiyol Derg. 2009 Jun;9(3):238-47. Review. Turkish.

PMID:
19520659
[PubMed - indexed for MEDLINE]
Free Article
3.

Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs.

Gore MO, McGuire DK.

Curr Cardiol Rep. 2009 Jul;11(4):258-63. Review.

PMID:
19563725
[PubMed - indexed for MEDLINE]
4.

Postprandial dysmetabolism and large-vessel disease.

Segal P.

Diabetes Nutr Metab. 2002 Dec;15(6 Suppl):3-8. Review.

PMID:
12702001
[PubMed - indexed for MEDLINE]
5.

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.

Valmadrid CT, Klein R, Moss SE, Klein BE.

Arch Intern Med. 2000 Apr 24;160(8):1093-100.

PMID:
10789601
[PubMed - indexed for MEDLINE]
6.

Glycemic targets for patients with type 2 diabetes mellitus.

Hamnvik OP, McMahon GT.

Mt Sinai J Med. 2009 Jun;76(3):227-33. doi: 10.1002/msj.20117.

PMID:
19421966
[PubMed - indexed for MEDLINE]
Free Article
7.

Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.

Zarich SW.

Rev Cardiovasc Med. 2003;4 Suppl 6:S19-28. Review.

PMID:
14668700
[PubMed - indexed for MEDLINE]
8.

Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.

Laakso M.

Prim Care. 1999 Dec;26(4):829-39. Review.

PMID:
10523462
[PubMed - indexed for MEDLINE]
9.

[Management of cardiovascular risk factors in type 2 diabetes mellitus].

Brändle M, Spinas GA.

Ther Umsch. 2002 Aug;59(8):415-21. German.

PMID:
12235734
[PubMed - indexed for MEDLINE]
10.

Postprandial glucose regulation and diabetic complications.

Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J.

Arch Intern Med. 2004 Oct 25;164(19):2090-5. Review.

PMID:
15505121
[PubMed - indexed for MEDLINE]
11.

Prandial glucose regulation and cardiovascular disease in type 2 diabetes.

Kuusisto J, Laakso M.

Eur J Clin Invest. 1999 Jun;29 Suppl 2:7-11. Review.

PMID:
10383604
[PubMed - indexed for MEDLINE]
12.

Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.

Roman G, Hancu N.

Horm Metab Res. 2009 Feb;41(2):116-22. doi: 10.1055/s-0028-1128144. Epub 2009 Feb 12. Review.

PMID:
19214921
[PubMed - indexed for MEDLINE]
13.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
14.

Antidiabetic agents and cardiovascular risk in type 2 diabetes.

Zarich SW.

Nat Rev Endocrinol. 2009 Sep;5(9):500-6. doi: 10.1038/nrendo.2009.150. Epub 2009 Jul 28. Review.

PMID:
19636325
[PubMed - indexed for MEDLINE]
15.

Primary prevention of cardiovascular disease in people with dysglycemia.

Bianchi C, Miccoli R, Penno G, Del Prato S.

Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. doi: 10.2337/dc08-s256. Review.

PMID:
18227487
[PubMed - indexed for MEDLINE]
16.
17.

Is it possible to reduce cardiovascular risk with glucose-lowering approaches?

Gerstein HC.

Nat Rev Endocrinol. 2009 May;5(5):270-5. doi: 10.1038/nrendo.2009.49. Review.

PMID:
19444260
[PubMed - indexed for MEDLINE]
18.

[Blood glucose control and cardiovascular disease in patients with type 2 diabetes. Results of ACCORD, ADVANCE and VA-Diabetes trials].

Radermecker RP, Philips JC, Jandrain B, Paquot N, Scheen AJ.

Rev Med Liege. 2008 Jul-Aug;63(7-8):511-8. French.

PMID:
18771232
[PubMed - indexed for MEDLINE]
19.

Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials.

Yki-Järvinen H.

Drugs. 2000 Nov;60(5):975-83. Review.

PMID:
11129129
[PubMed - indexed for MEDLINE]
20.

Risk factors for nephropathy in type 2 diabetes mellitus.

Rachmani R, Ravid M.

Compr Ther. 1999 Jun-Jul;25(6-7):366-9.

PMID:
10470521
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk